Earnings
BrightSpring Reiterates 2027 Profit Growth Goal And Says It Could Do '400 Of EBITDA' In Deals
The home-health and pharmacy company still expects at least 15% to 20% organic adjusted EBITDA growth in 2027, now off a larger 2026 base.
BrightSpring Health Services (BTSG) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The home-health and pharmacy company still expects at least 15% to 20% organic adjusted EBITDA growth in 2027, now off a larger 2026 base.
Markets
Third-quarter revenue climbed 26.4% to $4.21 billion, and BrightSpring raised its 2026 revenue and adjusted EBITDA guidance.
Earnings
Net income from continuing operations reached $101 million, and leverage dropped to 1.79x from 2.15x at the end of June.